Patents by Inventor Takefumi Yamaguchi

Takefumi Yamaguchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DIAGNOSTIC IMAGING SUPPORT DEVICE, DIAGNOSTIC IMAGING SUPPORT SYSTEM, AND DIAGNOSTIC IMAGING SUPPORT METHOD
    Publication number: 20230094530
    Abstract: A diagnostic imaging support device includes: a learning unit that calculates a feature quantity about each of infectiousness condition and non-infectiousness condition for determining a condition in a determination image of an anterior eye through machine learning on the basis of a learning image of an anterior eye and information about a condition in the learning image.
    Type: Application
    Filed: February 12, 2021
    Publication date: March 30, 2023
    Applicants: NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM, UNIVERSITY OF TSUKUBA
    Inventors: Kensaku MORI, Masahiro ODA, Tetsuro OSHIKA, Yuta UENO, Takefumi YAMAGUCHI, Hideki FUKUOKA
  • METHODS OF REDUCING CORNEAL ENDOTHELIAL CELL LOSS
    Publication number: 20180200339
    Abstract: Provided herein are methods of reducing corneal endothelial cell loss (e.g., nerve loss-related corneal endothelial cell loss) that include selecting a subject identified as having an eye with reduced numbers of corneal nerves as compared to a reference eye, e.g., an eye of a healthy control, and administering vasoactive intestinal peptide (VIP) or a nucleic acid encoding VIP to the selected subject.
    Type: Application
    Filed: August 25, 2017
    Publication date: July 19, 2018
    Inventors: Takefumi Yamaguchi, Ula Jurkunas, Pedram Hamrah
  • METHODS OF REDUCING CORNEAL ENDOTHELIAL CELL LOSS
    Publication number: 20160271224
    Abstract: Provided herein are methods of reducing corneal endothelial cell loss (e.g., nerve loss-related corneal endothelial cell loss) that include selecting a subject identified as having an eye with reduced numbers of corneal nerves as compared to a reference eye, e.g., an eye of a healthy control, and administering vasoactive intestinal peptide (VIP) or a nucleic acid encoding VIP to the selected subject.
    Type: Application
    Filed: November 20, 2014
    Publication date: September 22, 2016
    Inventors: Takefumi Yamaguchi, Ula Jurkunas, Pedram Hamrah